Search

Page 9 of 80
  • News
    Engineering next-generation precision therapies to treat a debilitating disease in children

    Florey researchers are working on precision medicines to treat ataxia-telangiectasia (A-T), a debilitating childhood disease.

    Read time: 3 mins

    View more
    ASOs
  • Document / Newsletter
    Brain Matters Autumn 2025

    Your source of neuroscience and mental health insights from The Florey. Learn about the latest the latest discovery into the role of inflammation in multiple sclerosis; meet 3 researchers representing and empowering change for women's health outcomes and care; and find out about our latest community events, where we showcase the important work being undertaken at The Florey.

    Read
  • News
    Streamlining epilepsy diagnosis and treatment

    Key points Epilepsy is the most common serious brain disorder globally. One in 25 Australians will be diagnosed with epilepsy at some stage in their lives. The Australian Epilepsy Project (AEP) is setting a new standard of care that simplifies the journey from diagnosis to treatment. Will Campbell was referred to the AEP where a small structural abnormality in his brain that was driving his…

    Read time: 4 mins

    View more
    Streamlining epilepsy diagnosis and treatment Australian Epilepsy Project
  • News
    New Florey Board Directors

    The Florey welcomes Professor Shelley Dolan and Jodie Geissler to its Board of Directors, and farewells Professor Christine Kilpatrick AO from the Board.

    Read time: 2 mins

    View more
    New Florey Board Directors Shelley Dolan and Jodie Geissler
  • News
    Ending stroke postcode lottery

    The Australian Stroke Clinical Registry (AuSCR), led by The Florey, was established to monitor stroke care across hospitals in Australia to improve patients' quality of life.

    Read time: 3 mins

    View more
    Dr Jackson Harvey and Mr Mike Lugg
  • Researcher
    Dr Laura Ellett PhD

    Research Officer

    Dr Ellett works in neurodegeneration research, focusing on prion disease. She has a background in nutrition, protein biochemistry and microbiology.

    View more
    Laura Ellett researcher profile
  • Research Project
    Assessing the therapeutic impact of chemogenetic stimulation of neuropeptide Y cortical interneurons in MND mouse models

    This study will establish whether targeting interneurons in the motor region of the brain is a potential therapeutic target for motor neurone disease.

    Learn more
    Accepting students
  • General / About us / Leadership
    Ms Jodie Geissler

    Ms Jodie Geissler joined The Florey Board of Directors in May 2025, and is Chief Executive Officer of Austin Health.

    View more
    Jodie Geissler leadership
  • General / About us / Leadership
    Professor Shelley Dolan

    Professor Shelley Dolan joined The Florey Board of Directors in May 2025. She is Chief Executive at the Royal Melbourne Hospital.

    View more
    Prof Shelley Dolan leadership
  • News
    Care work inspires search for epilepsy cure

    PhD student Montanna Waters' experience caring for Jaeli and Dali Williams, who live with SYNGAP1, inspired her to pursue epilepsy research at The Florey.

    Read time: 4 mins

    View more
    Montanna Waters with Jaeli and Dali Williams